These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 20673551

  • 1. Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report.
    Meyer RE, Salzman C, Youngstrom EA, Clayton PJ, Goodwin FK, Mann JJ, Alphs LD, Broich K, Goodman WK, Greden JF, Meltzer HY, Normand SL, Posner K, Shaffer D, Oquendo MA, Stanley B, Trivedi MH, Turecki G, Beasley CM, Beautrais AL, Bridge JA, Brown GK, Revicki DA, Ryan ND, Sheehan DV.
    J Clin Psychiatry; 2010 Aug; 71(8):1040-6. PubMed ID: 20673551
    [Abstract] [Full Text] [Related]

  • 2. Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement.
    Meyer RE, Salzman C, Youngstrom EA, Clayton PJ, Goodwin FK, Mann JJ, Alphs LD, Broich K, Goodman WK, Greden JF, Meltzer HY, Normand SL, Posner K, Shaffer D, Oquendo MA, Stanley B, Trivedi MH, Turecki G, Beasley CM, Beautrais AL, Bridge JA, Brown GK, Revicki DA, Ryan ND, Sheehan DV.
    J Clin Psychiatry; 2010 Aug; 71(8):e1-e21. PubMed ID: 20797373
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Assessing the role of drugs in suicidal ideation and suicidality.
    Reith DM, Edmonds L.
    CNS Drugs; 2007 Aug; 21(6):463-72. PubMed ID: 17521226
    [Abstract] [Full Text] [Related]

  • 6. Association between antidepressant half-life and the risk of suicidal ideation or behavior among children and adolescents: confirmatory analysis and research implications.
    Smith EG.
    J Affect Disord; 2009 Apr; 114(1-3):143-8. PubMed ID: 18692250
    [Abstract] [Full Text] [Related]

  • 7. The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.
    KoKoAung E, Cavenett S, McArthur A, Aromataris E.
    JBI Database System Rev Implement Rep; 2015 Apr 17; 13(3):174-205. PubMed ID: 26447056
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries.
    Rihmer Z, Akiskal H.
    J Affect Disord; 2006 Aug 17; 94(1-3):3-13. PubMed ID: 16712945
    [Abstract] [Full Text] [Related]

  • 11. Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA.
    McCall WV, Benca RM, Rosenquist PB, Riley MA, McCloud L, Newman JC, Case D, Rumble M, Krystal AD.
    Am J Psychiatry; 2017 Jan 01; 174(1):18-25. PubMed ID: 27609243
    [Abstract] [Full Text] [Related]

  • 12. Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population?
    Akiskal HS, Benazzi F.
    J Affect Disord; 2006 Aug 01; 94(1-3):105-10. PubMed ID: 16766043
    [Abstract] [Full Text] [Related]

  • 13. Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review.
    Möller HJ.
    Eur Arch Psychiatry Clin Neurosci; 2006 Dec 01; 256(8):476-96. PubMed ID: 17143567
    [Abstract] [Full Text] [Related]

  • 14. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration.
    Stone M, Laughren T, Jones ML, Levenson M, Holland PC, Hughes A, Hammad TA, Temple R, Rochester G.
    BMJ; 2009 Aug 11; 339():b2880. PubMed ID: 19671933
    [Abstract] [Full Text] [Related]

  • 15. [SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children].
    Tandt H, Audenaert K, van Heeringen C.
    Tijdschr Psychiatr; 2009 Aug 11; 51(6):387-93. PubMed ID: 19517368
    [Abstract] [Full Text] [Related]

  • 16. Use of selective serotonin reuptake inhibitors and youth suicide: making sense from a confusing story.
    Kutcher S, Gardner DM.
    Curr Opin Psychiatry; 2008 Jan 11; 21(1):65-9. PubMed ID: 18281842
    [Abstract] [Full Text] [Related]

  • 17. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S, Merry S, McKenzie J, Sindahl P, Proctor M.
    Cochrane Database Syst Rev; 2007 Jul 18; (3):CD004851. PubMed ID: 17636776
    [Abstract] [Full Text] [Related]

  • 18. Antidepressants and suicide: risk-benefit conundrums.
    Healy D, Whitaker C.
    J Psychiatry Neurosci; 2003 Sep 18; 28(5):331-7. PubMed ID: 14517576
    [Abstract] [Full Text] [Related]

  • 19. Are selective serotonin reuptake inhibitors a risk factor for adolescent suicide?
    Healy D.
    Can J Psychiatry; 2009 Feb 18; 54(2):69-71; discussion 76-7. PubMed ID: 19254434
    [No Abstract] [Full Text] [Related]

  • 20. Evaluating suicide-related adverse events in clinical trials of fluoxetine treatment in adults for indications other than major depressive disorder.
    Tauscher-Wisniewski S, Disch D, Plewes J, Ball S, Beasley CM.
    Psychol Med; 2007 Nov 18; 37(11):1585-93. PubMed ID: 17640442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.